MedCity Update – March 2016
View this email in your browser


From Sarah Haywood, MedCity’s CEO

From the very start of MedCity’s life, we have been absolutely clear that our focus must include the growth of medical and digital technologies as well as traditional biotech. That was reinforced back in autumn 2014 when Lord Darzi’s Better Health for London report proposed that London should make the most of its life sciences and tech strengths to lead the way in digital health commercialisation and adoption. So I’m really pleased that this week we have launched DigitalHealth.London and its associated Digital Health Accelerator, a project led by London’s three Academic Health Science Networks in partnership with MedCity to speed up the use of digital technologies and grow the digital health economy. More details on the initiative and on our first event for companies taking place in March are below.

Finally, a quick thank you to all those who joined us for last month’s Future of Healthcare Investor Forum – the second time we have held the event with the London Stock Exchange, with 2017’s event already in planning. I think everyone came out buoyed by the confidence and dynamism of UK life sciences, which was tangible throughout. You can read Sarah Haywood’s reflections on the event below. 

Digital health takes centre stage

Digital health represents “a noble opportunity” to change healthcare from something done to you into an age of empowered, active healthcare citizens, said George Freeman at the launch of DigitalHealth.London at City Hall. A partnership between the Health Innovation Network, Imperial College Health Partners, UCLPartners, MedCity and the Mayor of London, DigitalHealth.London aims to close the gap between companies and the NHS in order to speed up the use of digital technologies.  
Read more about DigitalHealth.London

Digital Health Accelerator – Information Day

Entrepreneurs and companies focused on digital health are invited to a free event on developing products in partnership with clinicians and healthcare experts. 
Find out more and book

A life sciences renaissance: the Future of Healthcare Investor Forum

It was standing room only to hear from a host of leading political, investment and industry figures at the second Future of Healthcare Investor Forum in January. 

Read Sarah Haywood’s reflections on the event and see new data that shows the continued strong performance of UK life sciences

Reminder – space demand study

Creative Places is leading a public/private initiative to explore demand from businesses and organisations involved in life sciences R&D activity for workspace in London and the wider region. If you have a current or potential R&D interest in London and want to influence future planning for growth and connectivity, please participate in this five minute online study

Read more about the study

New London Cancer Hub announced for Sutton

A new global hub for cancer research and treatment will be established by the Institute of Cancer Research, the Royal Marsden NHS Foundation Trust and the London Borough of Sutton. Photo: Feilden + Mawson architects  
Read more

UK universities join up with pharma to launch Apollo Therapeutics 

AstraZeneca, GSK and Johnson & Johnson have teamed up with Cambridge, Imperial and UCL to create Apollo Therapeutics – a £40m fund to turn science research into new medicines.
Find out more

UCL creates £50m tech investment fund 

A new technology fund has been launched by UCL to commercialise its research over the next five years, providing funding from proof of concept to commercialisation. and UCL to create Apollo Therapeutics – a £40m fund to turn science research into new medicines.
Find out more

Angels in MedCity investor workshop

The next event for people interested in finding out more about investing in life sciences companies takes place on Thursday 3 March from 6pm. The event aims to give an understanding of angel investment generally as well as opportunities in the life sciences and healthcare market.  
Find out more

New Accelerator Building ready to open at Stevenage 

Small companies that begin in one of the UK’s bioincubators will have extra room to develop, thanks to the new Stevenage Bioscience Catalyst Accelerator Building. The building is split between labs and offices with 4,100 square metres of working space for up to 150 people. For enquiries contact
Find out more about the Accelerator Building

Imperial ThinkSpace – available for pre-let

Imperial ThinkSpace offers the chance to co-locate with a leading research university. The eleven storey Translation & Innovation Hub opens in in July 2016 at White City, and future buildings will include the Molecular Sciences Research Hub and the Michael Uren Biomedical Engineering hub. For enquiries contact 
Find out more about ThinkSpace

Coming up

Drug re-purposing for rare diseases, Findacure, 29 February
UK MedEnterprise Training Network, Imperial College London, 10 March
Connecting Healthcare IT, Enterprise Europe Network, 19-21 April
Bio-Dundee International Conference, Bio-Dundee, 24-25 May
Short courses for entrepreneurs, UCL, ongoing

Email us to share your event 

MedCity was established in April 2014 by the Mayor of London with the Higher Education Funding Council for England and the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in March.


Copyright © 2016 MedCity. All rights reserved.